Management of Atrial Fibrillation in the Elderly - 2018
To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.
Starts On:
7/1/2019: 12:00 AM
Ends On:
6/30/2020: 12:00 AM
Session Type:
Internet Activity Enduring Material
Credits:
0.75
Description:
Professor, Cardiology
Director, Cardiac Rapid Evaluation Unit
Disclosures: Dr. Rich has nothing to disclose
Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, Cardiology Update 2018, June 2, 2018, which was supported in part by the Missouri Chapter of the American College of Cardiology, Actelion Pharmaceuticals and Edwards Lifesciences.
• Financial Relationship: Nothing to disclose
Heidi E. Craddock, FNP, BC, Family Nurse Practitioner, Cardiovascular Division
• Financial Relationship
Speakers Bureau/Honoraria: Novartis Pharma AG
Edward M. Geltman, MD, FACC, Course Chair
• Financial Relationships
Speakers Bureau/Honoraria: Amgen, Inc.
Consulting/Advisory Committees: Novartis Pharma AG
Andrew M. Kates, MD, FACC
• Financial Relationship: Nothing to disclose
Philip A. Ludbrook, MD, FACC, FRACP
Professor Emeritus of Medicine and Psychiatry, Cardiovascular Division
• Financial Relationship: Nothing to disclose
Jerrica Shuster, PharmD, BCPS AQ – Cardiology
Clinical Pharmacy Specialist, Heart Failure/LVAD/Transplant, BJC
• Financial Relationship
Speakers' Bureau/Honoraria: Janssen
Faculty
Michael W. Rich, MDProfessor, Cardiology
Director, Cardiac Rapid Evaluation Unit
Disclosures: Dr. Rich has nothing to disclose
Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, Cardiology Update 2018, June 2, 2018, which was supported in part by the Missouri Chapter of the American College of Cardiology, Actelion Pharmaceuticals and Edwards Lifesciences.
Planning Committee
David L. Brown, MD, Professor of Medicine, Cardiovascular Division• Financial Relationship: Nothing to disclose
Heidi E. Craddock, FNP, BC, Family Nurse Practitioner, Cardiovascular Division
• Financial Relationship
Speakers Bureau/Honoraria: Novartis Pharma AG
Edward M. Geltman, MD, FACC, Course Chair
• Financial Relationships
Speakers Bureau/Honoraria: Amgen, Inc.
Consulting/Advisory Committees: Novartis Pharma AG
Andrew M. Kates, MD, FACC
• Financial Relationship: Nothing to disclose
Philip A. Ludbrook, MD, FACC, FRACP
Professor Emeritus of Medicine and Psychiatry, Cardiovascular Division
• Financial Relationship: Nothing to disclose
Jerrica Shuster, PharmD, BCPS AQ – Cardiology
Clinical Pharmacy Specialist, Heart Failure/LVAD/Transplant, BJC
• Financial Relationship
Speakers' Bureau/Honoraria: Janssen
Objectives:
The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
- Explain the role of traditional and novel drug and non-drug therapies in the management of atrial fibrillation in older adults.
Additional Information:
Target Audience: This course is designed for internal medicine and family practice physicians, cardiologists, cardiac surgeons, physician assistants, geriatricians, pharmacists, nurses (including advance practice and clinical nurses) as well as all allied health professionals, on a range of relevant topics related to managing patients with, or at risk for, cardiovascular disease.
Publication Date: July 1, 2019
Expiration Date: June 30, 2020
Target Audience: This course is designed for internal medicine and family practice physicians, cardiologists, cardiac surgeons, physician assistants, geriatricians, pharmacists, nurses (including advance practice and clinical nurses) as well as all allied health professionals, on a range of relevant topics related to managing patients with, or at risk for, cardiovascular disease.
Publication Date: July 1, 2019
Expiration Date: June 30, 2020
Accreditation Information:
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Awarded for this Activity:
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Awarded for this Activity:
Credit Statement:
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
References:
- JAMA 2001;285:2370-2375
- Arch Intern Med 1995;155:469-73
- Circulation 2005;112:1687-1691
- N Engl J Med 2002;347:1825-33
- Lancet 2007;370:493-503
Disclosure Information:
It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
